Anesthesia Ocular

Updated: June 21, 2024

Background

Epidemiology

Anatomy

Pathophysiology

Etiology

Genetics

Prognostic Factors

Clinical History

Physical Examination

Age group

Associated comorbidity

Associated activity

Acuity of presentation

Differential Diagnoses

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

Medication

tetracaine

Indicated for Ophthalmic:

minor surgical procedures: 1-2 drops into the affected eye every 5-10 min
Short term anaesthesia:1-2 drops into each affected eye every 5-10 mins
Prolonged surgical procedure: 1-2 drops into each affected eye every 5-10 mins. Do not exceed five doses

chloroprocaine ophthalmic

Indicated for ocular surface anesthesia
Administer three gtts onto the surface of the eye region by topical application where the procedure is scheduled to take place
You can reapply as necessary to sustain the anesthetic effect

Future Trends